StonvexLoading…
StonvexStonvexStonvexCore line items from SNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $36.37M | $35.75M | $32.79M | $35.56M |
Operating Income | $3.01M | $3.88M | $-1.26M | $1.48M |
Net Income | $3.22M | $2.64M | $-1.29M | $3.83M |
EPS (Diluted) | $0.14 | $0.11 | $-0.06 | $0.16 |
Total Assets | $54.67M | $52.08M | $50.27M | $51.89M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $22.34M | $20.47M | $14.81M | $14.94M |
Free Cash Flow OCF − CapEx | $1.20M | $6.38M | $-120.00K | $-9.67M |
Shares Outstanding | 23.33M | 23.33M | 23.31M | 23.31M |